Tenet Healthcare (THC) Tops Q4 EPS by $3.02, Revenues Beat; Offers 1Q & FY21 EPS/Revenue Outlook

Go back to Tenet Healthcare (THC) Tops Q4 EPS by $3.02, Revenues Beat; Offers 1Q & FY21 EPS/Revenue Outlook

Tenet Reports Fourth Quarter 2020 Results; Announces Plan to Retire $478 million of Debt; Provides 2021 Financial Guidance

February 9, 2021 4:10 PM EST

Net income from continuing operations available to common shareholders in 4Q20 of $414 million versus a net loss from continuing operations of $3 million in 4Q19 Consolidated Adjusted EBITDA in 4Q20 of $832 million excluding $446 million of COVID stimulus grant income, or $1.278 billion including the grant income, versus $799 million in 4Q19 Diluted earnings per share from continuing operations available to common shareholders in 4Q20 of $3.86 compared to a loss per share of $0.03 in 4Q19; Adjusted diluted earnings per share from continuing operations of $4.72 in 4Q20... More